BKBong-Jo Kim

Bong-Jo Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bong-Jo Kim has a total of 243 co-authors. Here are the top co-authors by number of shared publications:

  • Young Jin Kim

    Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea

    16 shared publications
  • Jun Ho Yun

    Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, 28159, Republic of Korea

    6 shared publications
  • Hye-Mi Jang

    Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju, Korea

    5 shared publications
  • Dong Mun Shin

    Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju, Republic of Korea

    4 shared publications
  • Mi Yeong Hwang

    Division of Genome Research, Center for Genome Science, National Institute of Health, Osong Health Technology Administration Complex

    4 shared publications
  • Mi Yeong Hwang

    Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea

    4 shared publications

Latest Publications

  • Open Access

    Immune pathway activation in gastric cancers with LINE-1 retrotransposon overexpression and homologous recombination deficiency

    by Young Jin Kim, In-Pyo Baek, Bang Wool Eom, Min-Jung Seo, Heeyeon Joo, Yu Ri Choi, Min Kyoung Park, Jihye Oh, Boram Lee, Seung Min Ham, et al.

    There are only a few whole genome sequencing studies of human gastric cancer (GC) conducted so far. We performed comprehensive whole genome, bulk RNA, and methylation sequencing analyses of 100 samples of GC and adjacent normal tissue. In a smaller non-EBV/non-MSI subset ( n = 23), we also performed proteomic profiling by mass spectrometry. We validated the proteomic findings in an independent dataset. Using this unprecedented dataset of human GC samples, we examined the extent of chromothripsis, homologous recombination deficiency, and retrotransposition, and correlated these events with patient outcomes. We found that chromothripsis occurred in 22% of GCs and correlated with poor prognosis. Multichromosomal chromothripsis was associated with a particularly high risk of death. Based on copy number (CN) signature analysis, we identified a distinct non-CN9 subgroup with significantly worse outcomes. Homologous recombination deficiency was present in 4% of GCs and was associated with overexpression of immune signaling pathways. Somatic retrotransposition events were most strongly associated with global hypomethylation. We also identified BYSL as a putative oncogenic driver within the 6p21 locus whose amplification is associated with poor prognosis. Collectively, our findings provide novel insights into the dysregulation of DNA stability and repair and their clinical relevance in human GCs.

  • Open Access

    Long-read sequencing reveals novel mitochondrial genome variants undetected by short-read sequencing in Korean population

    by Hyung Jun Kim, Sung Min Kim, Kyungheon Yoon, Bong-Jo Kim, Han Jun Jin, Young Jin Kim

    While long-read sequencing technologies (e.g., PacBio Revio, ONT) have revolutionized high-quality genome assembly for the human pangenome, mitochondrial genome (mtDNA) analysis still largely relies on short-read and Sanger sequencing. However, short-read sequencing often lacks the resolution required to resolve complex variations due to the unique features of mtDNA, such as high mutation rates and repetitive homopolymeric regions, which frequently lead to alignment artifacts and mapping ambiguities. To address this, we evaluated whether applying long-read sequencing to mtDNA improves analytical quality in empirical data. Through comprehensive bioinformatics analyses, we compared the performance of long-read sequencing against short-read sequencing and microarrays. Our results revealed that long-read sequencing detected the highest number of variants (n = 533), significantly outperforming both short-read sequencing (n = 525) and microarrays (n = 49). Notably, both sequencing methods provided significantly higher resolution in haplogroup assignment compared to microarrays in terms of phylogenetic depth (p < 0.05). Long-read sequencing demonstrated superior detection power, particularly for InDels. We identified two novel non-synonymous variants, including a unique InDel detected exclusively by long-read sequencing. Protein modeling and stability analysis validated that this InDel causes structural instability (RMSD > 2.0 Å, 𝛥𝛥G = -45.21 kcal/mol). Furthermore, we confirmed that this novel InDel is shared among haplogroup A samples in both the 1000 Genomes Project ONT dataset and the Korean population, highlighting the practical implications of long-read sequencing for molecular biology and population genetics.

  • Open Access

    SAMM50 rs3761472 causes mitochondrial dysfunction and progression of metabolic dysfunction-associated steatotic liver disease

    by Suyeon Kim, Young Jin Kim, Nahyun Kim, Uijin Kim, Yi Seul Park, Jun Ho Yun, Jiwon Heo, Hyunwoo Lee, Jiwon Choi, Sinwoo Park, et al.

  • Open Access

    A draft Korean pangenome graph from 264 assemblies reveals intrapopulation structural variation and improves ancestry-matched variant analysis

    by Jun Kim, Bong-Jo Kim, Young Jin Kim, Nak-Hyeon Choi, Sung Min Kim, Jiseon Lim, Seoyeon Kim, Kyungheon Yoon, Mi Yeong Hwang, Seung Jae Lee, et al.

    Human pangenome studies have improved representation across populations, but intrapopulation variation in homogeneous populations remains undercharacterized. Here we present a draft Korean pangenome from 264 Korean assemblies, including 8 near-T2T-level assemblies from 4 deeply sequenced individuals, as a pilot for the Korean Pangenome Project to generate 1,000 T2T-level genomes. We identified 20,194,050 SNVs, 5,406,444 small indels, 172,368 structural variants, and 1,521,240 assembly-based variants absent from major public resources. Segmental-duplication analysis defined 6,282 loci spanning 249.0 Mb and revealed Korean-enriched copy-number patterns at ARHGEF5 , AMY1/AMY2A , and C4A/C4B . The Korean pangenome graph contained 25,785,548 graph-derived variants, with 399.6 Mb of Korean private-to-low-shared sequence in the merged graph. In benchmarking, the KPP graph markedly improved SV and InDel detection over HPRC and CPC, especially in medically relevant genes and immune loci including KIR and MHC. These results establish KPP as a foundation for population-specific graph genomics in East Asia.

  • Genetic Landscape of Kidney Failure in a Korean Transplant Cohort

    by Hee Jung Jeon, Hye-Mi Jang, Yi Seul Park, Sung Min Kim, Bong-Jo Kim, Hyung Woo Kim, Jong Cheol Jeong, Seokwoo Park, Borae G. Park, Myoung Soo Kim, et al.

    Background: Kidney failure represents the final, irreversible stage of chronic kidney disease (CKD), yet its genetic architecture remains incompletely defined compared to CKD. While prior studies largely focused on kidney function traits, the genetic determinants of kidney failure itself and its etiologic subtypes are poorly understood. Therefore, this study aimed to identify genetic loci associated with kidney failure and its subtypes and to evaluate the predictive performance of multiple polygenic risk scores (PRSs) for stratifying kidney failure risk. Methods: We performed a large-scale genome-wide association study (GWAS) using a dataset of 2,355 kidney failure patients across three subtypes defined by primary disease, along with 152,131 controls. PRSs for type 2 diabetes, hypertension, estimated glomerular filtration rate (eGFR), and CKD were calculated, and a multi-PRS model was derived. Results: The GWAS identified multiple kidney failure-associated loci, including HLA-DRB1 for all kidney failure and glomerulonephritis as the primary disease, and COL24A1 for hypertensive kidney failure at genome-wide significance (P-8 ), implicating distinct immune and hypertension-related pathways in kidney failure pathogenesis. PRS analysis revealed that genetically distinct components of type 2 diabetes, hypertension, CKD, and eGFR were significantly linked to kidney failure risk across subtypes (OR=1.1–2.5). A combined multi-PRS model demonstrated superior predictive performance (OR=1.5–2.5). Comparison with CKD cohorts, predominantly influenced by eGFR-related genetics, uncovered unique kidney failure-specific genetic signatures, highlighting kidney failure as a genetically heterogeneous and multifactorial disease beyond CKD. Conclusions: This study identified subtype-specific genetic loci and demonstrated that multi-PRS models improve kidney failure risk prediction beyond basic available clinical factors.

  • Open Access

    Middle-Aged Carotid Plaque and Cognitive Functions in Later Life

    by Gisung Shin, Ali Tanweer Siddiquee, Min-Hee Lee, Yoonho Hwang, June Christoph Kang, Seung Ku Lee, Youngjin Kim, Bongjo Kim, Chol Shin, Nanhee Kim

    Background and ObjectivesCarotid plaque reflects systemic atherosclerosis and may serve as an early marker of cognitive decline, but its longitudinal association with cognitive trajectories remains...

  • Open Access

    Accelerating genetic diagnosis in the NICU: neonatologist-driven rapid whole genome sequencing

    by Hye-Won Cho, Jeong-Min Kim, Sung Hyeon Park, Hyeseon Kim, Dong Mun Shin, Ho-Yeong Yu, Misun Yang, So Yoon Ahn, Se In Sung, Bong-Jo Kim, et al.

    To establish a rapid whole-genome sequencing (rWGS) workflow applicable to the neonatal intensive care unit (NICU) setting and evaluate its diagnostic utility and clinical feasibility. Twenty critically ill neonates with suspected genetic disorders were included in this study. A workflow for rWGS encompassing neonate enrollment through to the return of genetic diagnosis results was established. A trio-based rWGS data analysis was performed using DRAGEN-GATK-Hail, with results reviewed and reported by a multidisciplinary team. The average turnaround time for the 20 NICU neonates was 5.5 working days. Genetic diagnoses were achieved in ten cases, resulting in a diagnostic yield of 50%, based on the clinical database and variant pathogenicity assessments. The identified diagnostic variants were located across nine genes, including AGT, ANK1, NSD1, SERPINC1, OTC (in two cases), INS, PKHD1, SAMD9, and LZTR1. The clinical implications were confirmed in all ten diagnosed neonates, with 'genetic counseling and recurrence risk management', 'early therapeutic decision-making' and 'enhancement of clinical outcomes and survival rates'. Notably, neonate rWGS-03 demonstrated the highest impact, as rWGS enabled the early identification of renal tubular dysgenesis before symptom onset. This study demonstrates the feasibility of rWGS for critically ill neonates with suspected genetic disorders admitted to the NICU. As the first implementation of neonatologist-driven rWGS in Korea, it highlights the meaningful clinical benefits of timely and accurate diagnosis. Our findings underscore its clinical value and support the integration of rWGS into routine clinical care, as well as the development of future studies within public healthcare systems.

  • Open Access

    SLC30A8 Rare Variant Modify Contribution of Common Genetic and Lifestyle Factors toward Type 2 Diabetes Mellitus

    by Hye-Mi Jang, Mi Yeong Hwang, Yi Seul Park, Bong-Jo Kim, Young Jin Kim

    Background: This study aimed to investigate the modifying effects of rare genetic variants on the risk of type 2 diabetes mellitus (T2DM) in the context of common genetic and lifestyle factors.Methods: We conducted a comprehensive analysis of genetic and lifestyle factors associated with T2DM in a cohort of 146,284 Korean individuals. Among them, 4,603 individuals developed T2DM during the follow-up period of up to 17 years. We calculated a polygenic risk score (PRS) for T2DM and identified carriers of the rare allele I349F at SLC30A8. A Healthy Lifestyle Score (HLS) was also derived from physical activity, obesity, smoking, diet, and sodium intake levels. Using Cox proportional hazards models, we analyzed how PRS, HLS, and I349F influenced T2DM incidence.Results: Results showed that high PRS and poor lifestyle were associated with increased risk. Remarkably, I349F carriers exhibited a lower T2DM prevalence (5.7% compared to 11.7% in non-carriers) and reduced the impact of high PRS from 23.18% to 12.70%. This trend was consistent across different HLS categories, with I349F carriers displaying a lower risk of T2DM.Conclusion: The integration of common and rare genetic variants with lifestyle factors enhanced T2DM predictability in the Korean population. Our findings highlight the critical role of rare genetic variants in risk assessments and suggest that standard PRS and HLS metrics alone may be inadequate for predicting T2DM risk among carriers of such variants.


  • Development of an MHC imputation panel highlights independent contributions of HLA amino acid residues and C4 copy number variations to SLE risk

    by Chae-Yeon Yu, Dong Mun Shin, Sung Min Kim, Yui Taek Lee, Sungwon Jeon, Sehwan Chun, So-Young Bang, Hye-Soon Lee, Xianyong Yin, Yong Cui, et al.


  • Open Access

    The SAMM50 rs3761472 causes mitochondrial dysfunction and metabolic dysfunction-associated steatotic liver disease

    by Suyeon Kim, Nahyun Kim, Uijin Kim, Young Jin Kim, Jun Ho Yun, Jiwon Heo, Hyunwoo Lee, Jiwon Choi, Inhae Jeong, Bong-Jo Kim, et al.

    Genome-wide association studies (GWAS) have identified the SAMM50 rs3761472 single nucleotide polymorphism (SNP) as a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), although its in vivo functions remain unclear. SAMM50 encodes a mitochondrial outer membrane protein critical for maintaining mitochondrial structure. To investigate the biological effects of rs3761472, we generated Samm50 -knock-in (KI) mice harboring a D110G substitution using CRISPR/Cas9. This variant impaired mitochondrial integrity by downregulating key regulators of mitochondrial architecture, dynamics, and quality control. This contributed to reduced ATP production and elevated oxidative stress, inflammation, and hepatocyte death. The mutation also induced insulin resistance and glucose intolerance. Samm50 -KI mice fed a high-fat diet exhibited pronounced hepatic lipid accumulation and liver injury, highlighting its pathogenic role in MASLD progression. Our findings demonstrate that SAMM50 rs3761472 is a critical driver of mitochondrial dysfunction and MASLD susceptibility, supporting its potential as a therapeutic target and its relevance to precision medicine.